Solvias Achieves Strong Sustainability Assessment from EcoVadis
On March 10, 2025, Solvias, an international provider of chemistry analytics, manufacturing, and control services, announced its commendable achievement of receiving an EcoVadis badge. This badge, awarded after a thorough evaluation, positions Solvias among the top performers in sustainability out of more than 100,000 companies assessed by EcoVadis globally. This significant accomplishment underscores Solvias' unwavering commitment to integrate environmental, social, and governance (ESG) principles into its business practices.
Since launching its ESG initiative in 2024, Solvias has made remarkable strides in establishing a robust sustainability framework. The company has calculated its carbon footprint, set clear sustainability goals, and developed a comprehensive five-year action plan aimed at reducing its environmental impact and driving meaningful change. This proactive approach is part of Solvias' dedication to fostering a more sustainable future.
The positive assessment from EcoVadis provides Solvias with a solid foundation to further its sustainability efforts. In alignment with its commitment, the company will officially join the Science Based Targets initiative (SBTi) in the upcoming months. This global organization aids companies in curbing their greenhouse gas emissions, significantly reinforcing Solvias' long-term sustainability strategy.
Archie Cullen, CEO of Solvias, remarked, "Our first EcoVadis assessment is a pivotal milestone, validating our progress and motivating us to focus on meaningful changes. We are proud of how far we’ve come, and we remain fully committed to effectively embedding sustainability throughout our operations."
Solvias is already implementing initiatives under its five-year plan to achieve its sustainability targets. The company's efforts center around continuous improvement, attaining better ratings, and making measurable contributions towards a more sustainable future. With a dedicated team of experts and a wealth of experience in regulatory affairs regarding small molecules, biological products, and advanced therapies, Solvias is uniquely positioned to lead by example in the life sciences industry.
Based near Basel, Switzerland, Solvias operates six global centers of excellence that adhere to strict ISO, GMP, GLP, and FDA standards, ensuring high-quality service delivery across all dimensions of its operations. The company offers end-to-end solutions from raw material testing to the release of pharmaceuticals and active ingredient development for small molecules.
For more information on Solvias and its commitment to sustainability practices, visit
solvias.com. For media inquiries, reach out to Katy McGirr, Global Marketing Director, at [email protected] or call +1 617 513 8287.